Avantor (AVTR) Reports Q1 2025 Results Focused on Cost Management

Avantor, Inc. (NYSE:AVTR) reported Q1 2025 results reflecting disciplined execution and a focus on cost management. Lab Solutions revenue was impacted by lower demand, particularly in Education and Government markets. The company aims to achieve $400 million in gross run-rate savings by 2027.

Avantor (AVTR) continues driving conversion and margins with its cost transformation initiative, while offering critical materials in its Bioscience production segment. The company is making significant changes to fuel growth in the Lab business and enhancing supply chain efficiency. Digital enhancements and pricing optimization are also priorities.

Broyhill Asset Management’s Q1 2025 investor letter noted Avantor, Inc. (NYSE:AVTR) shares declined 23% due to policy uncertainty affecting academic and pharmaceutical industries. They believe the market is undervaluing AVTR’s strong growth potential and have continued building their position in the company.

While AVTR shows investment potential, Broyhill Asset Management sees greater upside in certain AI stocks. They suggest exploring an undervalued AI stock with potential benefits from Trump-era tariffs and onshoring trends.

Read more at Yahoo Finance: Avantor (AVTR) Q1 2025 Results Reflects Focus on Cost Management